SIRT1 and cancer: Many previous studies have reported the cancer‐promoting potential of USP22, including the induction of cell proliferation and DNA repair [34], activation of c‐Myc/NAMPT/SIRT1‐dependent FOXO1 and YAP signaling [35], and deubiquitination of CD274 to suppress anticancer immunity [36].